Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2006. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | Drug-related disorder | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Drug | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | Complication | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Pharmaceutical / biologic product (product) | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Drug, medicament or biological substance | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Pharmaceutical / biologic product (product) | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | Adverse reaction caused by substance | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Substance | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. | true | Inferred relationship | Some | 1 | |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | Adverse reaction (disorder) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Nicotine adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Monoamine oxidase inhibitor adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Tamoxifen adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Selective serotonin re-uptake inhibitor adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Azelastine adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Hydroxyzine adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Dimenhydrinate adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Butyrophenone adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Corticosteroids adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to caffeine | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Treosulfan adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Nabilone adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Domperidone adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Metoclopramide adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Bismuth chelate adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Deoxyribonuclease adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Hyaluronidase adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Chymotrypsin adverse reaction (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Vasopressor adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Circulatory topical preparations adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Hemorrhoid preparation adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Intravenous nutrition adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Fat hypertrophy due to injection of drug or medicament (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Acarbose adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Dornase alfa adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Tyloxapol adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Methylcysteine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Acetylcysteine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to hormone | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antithyroid drug adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Cyclofenil adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Anti-androgens adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Human immunoglobulin adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Anti-D (Rh) immunoglobulin adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Varicella-zoster immunoglobulin adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by antiserum (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to bromhexine | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to hyaluronic acid (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to allergenic extract (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
H2 receptor antagonist adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Proton pump inhibitor adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Carbenoxolone adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
A rare localised lipodystrophy characterised by the appearance of asymptomatic, well-demarcated, variably sized, depressed, lipoatrophic lesions secondary to subcutaneous, intradermic or intramuscular drug injection, including corticosteroids, insulin, human growth hormone and antibiotics. Skin colouration may vary from white or hypopigmented to reddish, pinkish or violaceous. Epidermal atrophy may be also present. | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to macromolecular blood substitutes | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Sweet's disease caused by drug | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to chenodeoxycholic acid and/or ursodeoxycholic acid | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Clofibrate adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Chlorpheniramine adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Diphenylpyraline adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to sulfonyluric hypoglycemic (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to biguanide oral hypoglycemic agent | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Loperamide adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to platelet aggregation inhibitor (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to bile acid and/or bile acid derivative (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Iron adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to tocilizumab (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to sarilumab (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to casirivimab and/or imdevimab | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Morphinan opioid adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Oestrogen antagonist adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Cetirizine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Dialysis fluid adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Plasma substitutes adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Loratadine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Clemastine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antazoline adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Promethazine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Azatadine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Cyproheptadine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Pheniramine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to meclozine (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Industrial methylated spirit adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to ethanol | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
At increased risk for negative response to medication (finding) | This attribute specifies the realization of a function | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | 2 |
At increased risk of negative response to patient controlled analgesia (finding) | This attribute specifies the realization of a function | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | 2 |
Nurse controlled analgesia is a technique by which the nurse or health professional licensed to administer medications, gives the patient a pre-programmed amount of an intravenous or subcutaneous analgesic solution as a bolus dose by the press of a button. | This attribute specifies the realization of a function | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | 2 |
Chorea caused by oral contraceptive (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug-induced chorea | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by psychotropic agent (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Norepinephrine reuptake inhibitor adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by synthetic cannabinoid (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Cataract of left eye caused by medication | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Cataract of right eye caused by medication (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug-induced pneumonitis | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Assessment of medication-induced extrapyramidal symptoms (procedure) | Has focus | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | 2 |
Adverse reaction to biguanide hypoglycemic agent (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some |
This concept is not in any reference sets